Eagle Pharmaceuticals (EGRX)

$1.65 -0.15 (-8.33%)
Market Cap 23.38M
Revenue (ttm) 316.61M
Net Income (ttm) 35.64M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 11.26%
Debt to Equity Ratio 0.28
Volume 501
Avg Vol 7,928
Day's Range N/A - N/A
Shares Out 12.99M
Stochastic %K 82%
Beta 0.83
Analysts Strong Buy
Price Target $17.00

Company Profile

Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a read...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 201 326 5300
Address:
50 Tice Boulevard, Suite 315, Woodcliff Lake, United States
Biocuda
Biocuda Oct. 30 at 5:41 PM
$EGRX it’s funny that Tarriff had to sue eagle to hold the annual shareholder meeting since they haven’t had one since 2023. You would think they know what the law is. https://www.law.com/radar/card/de-na-545898-tariff-v-eagle-pharmaceuticals-inc
1 · Reply
11thestate
11thestate Oct. 30 at 2:01 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
tdappello
tdappello Oct. 17 at 8:01 PM
$EGRX what is going on here?
0 · Reply
Biocuda
Biocuda Oct. 17 at 2:54 PM
$EGRX did anyone join the stockholders meeting? Anything interesting?
0 · Reply
honestinvt7672
honestinvt7672 Oct. 15 at 10:44 PM
$EGRX now is the time for Natahala and his buddies to bankrupt Egrx and take it all for themselves
1 · Reply
honestinvt7672
honestinvt7672 Oct. 12 at 6:42 AM
$EGRX Scum-Scott Tariff
1 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:39 AM
$EGRX audited financials published quicker than expected, when do they uplist?
3 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:31 AM
$EGRX $43M in operating profit and they spend $49M on R&D...
0 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 13 at 5:01 PM
$EGRX how big do you think revenues are now? I like the new board memeber
1 · Reply
honestinvt7672
honestinvt7672 Aug. 19 at 6:06 AM
$EGRX Anyone going to the Meeting? What a joke
2 · Reply
Latest News on EGRX
No data available.
Biocuda
Biocuda Oct. 30 at 5:41 PM
$EGRX it’s funny that Tarriff had to sue eagle to hold the annual shareholder meeting since they haven’t had one since 2023. You would think they know what the law is. https://www.law.com/radar/card/de-na-545898-tariff-v-eagle-pharmaceuticals-inc
1 · Reply
11thestate
11thestate Oct. 30 at 2:01 PM
Imagine buying $EGRX at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $EGRX investors out there, we’ve got some important news for you: https://11th.com/cases/eagle-investor-suit
0 · Reply
tdappello
tdappello Oct. 17 at 8:01 PM
$EGRX what is going on here?
0 · Reply
Biocuda
Biocuda Oct. 17 at 2:54 PM
$EGRX did anyone join the stockholders meeting? Anything interesting?
0 · Reply
honestinvt7672
honestinvt7672 Oct. 15 at 10:44 PM
$EGRX now is the time for Natahala and his buddies to bankrupt Egrx and take it all for themselves
1 · Reply
honestinvt7672
honestinvt7672 Oct. 12 at 6:42 AM
$EGRX Scum-Scott Tariff
1 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:39 AM
$EGRX audited financials published quicker than expected, when do they uplist?
3 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 18 at 1:31 AM
$EGRX $43M in operating profit and they spend $49M on R&D...
0 · Reply
worldslargestpenguin
worldslargestpenguin Sep. 13 at 5:01 PM
$EGRX how big do you think revenues are now? I like the new board memeber
1 · Reply
honestinvt7672
honestinvt7672 Aug. 19 at 6:06 AM
$EGRX Anyone going to the Meeting? What a joke
2 · Reply
worldslargestpenguin
worldslargestpenguin Aug. 9 at 1:53 PM
$EGRX anyone a fan of this company? what's next?
1 · Reply
LeoK_Lmnt88
LeoK_Lmnt88 Jul. 23 at 3:29 PM
$EGRX ⁨ ⁨Retail traders are actively loading up WKSP suggests growing interest ahead of a potential move; watching the 4.00 level closely⁩
1 · Reply
zoomlik
zoomlik Jul. 20 at 2:30 AM
$EGRX Don’t think we can buy or sell it.
2 · Reply
mikefbi
mikefbi Jul. 18 at 1:22 AM
$EGRX Still super
0 · Reply
Luckyluciano
Luckyluciano Jul. 11 at 12:10 PM
$EGRX Why is this moving up so much on no news? Entire market going up & up & up ”just because!” Just like the real estate market used to.
0 · Reply
honestinvt7672
honestinvt7672 Jul. 1 at 4:48 AM
$EGRX Looks like they moved out :50 Tice Blvd, Suite 315 Woodcliff Lake, NJ 07677 +1 (201) 326-5300
0 · Reply
honestinvt7672
honestinvt7672 Jun. 26 at 6:36 AM
$EGRX Great news, the Trial delayed to 2027.
0 · Reply
zoomlik
zoomlik Jun. 20 at 7:57 PM
$EGRX I have 5,000 shares here
1 · Reply
Biocuda
Biocuda Jun. 5 at 7:15 PM
$EGRX cal02 trial status now shows suspended
1 · Reply
mikefbi
mikefbi May. 30 at 1:42 PM
$EGRX Small position
1 · Reply
FLOoZzY_87MicaSlip
FLOoZzY_87MicaSlip May. 28 at 5:43 PM
$EGRX 🚨 NASDAQ: JFB - Watching $7 Into the 3PM? 🚨 Seeing increased chatter around a potential large-scale contract (rumored $1B+ - not confirmed). Volume remains elevated, and momentum looks intact. Price moved cleanly through $6.18, and eyes are now on the $7 level as we head toward the afternoon session. With a low float, growing project pipeline, and strong price action, this is definitely one to keep on the radar. Technical setup looks solid, sentiment continues to build - monitoring closely. 📈 ⚠️ Not a recommendation. Just my perspective - always do your own research.
0 · Reply
11thestate
11thestate May. 21 at 11:18 AM
$EGRX stockholders filed a claim against Eagle Pharmaceuticals for allegedly overstating revenue and failing to disclose issues related to PEMFEXY® sales and financial reporting. You can join this case to be notified about any new information: https://11th.com/cases/eagle-investor-suit
0 · Reply